Literature DB >> 15848631

The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation.

H Isoniemi1, A-M Koivusalo, H Repo, I Ilonen, K Höckerstedt.   

Abstract

In acute liver failure (ALF), detoxification capacity of liver cells is reduced and a variety of cytokines, immune modulators, and toxic substances are accumulating. Multiple organ failure in ALF has been associated with increased blood cytokine levels. We have used a blood purification system, molecular adsorbent recirculating system (MARS), which is based on removal of both protein bound and water-soluble substances and toxins in liver failure. In this study, we measured the effect of MARS therapy on plasma cytokine levels in 49 patients with ALF. Interleukin 6 (IL-6), IL-8, IL-10 and tumor necrosis factor (TNF)alfa were determined immediately before and after the first MARS therapy and after the last session using enzyme-linked immunosorbent assays. The overall survival of these ALF patients was 82% at 6 months; the native liver recovered in 26 cases, and 14 were successfully transplanted. All three interleukins were increased before the MARS treatment but only anti-inflammatory IL-10 was reduced significantly during therapy, which in this setting could be interpreted as a positive effect. We were not able to show constant decreases in proinflammatory cytokines, but only transient effects on IL-8 and IL-6. Surprisingly TNFalfa level was normal and did not change during therapy. In theory, MARS albumin dialysis may remove toxic substances from the blood circulation and thereby improve the possibilities of the liver to recover; however, of the measured cytokines only IL-10 decreased significantly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848631     DOI: 10.1016/j.transproceed.2004.11.060

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation.

Authors:  Christophe Camus; Sylvain Lavoué; Arnaud Gacouin; Yves Le Tulzo; Richard Lorho; Karim Boudjéma; Christian Jacquelinet; Rémi Thomas
Journal:  Intensive Care Med       Date:  2006-08-29       Impact factor: 17.440

2.  Blood cytokine, chemokine and gene expression in cholestasis patients with intractable pruritis treated with a molecular adsorbent recirculating system: a case series.

Authors:  Luiz F Lisboa; Sonal Asthana; Andreas Kremer; Mark Swain; Sean M Bagshaw; Noel Gibney; Constantine J Karvellas
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

3.  Liver transplantation().

Authors:  M Rossi; G Mennini; Q Lai; S Ginanni Corradini; F M Drudi; F Pugliese; P B Berloco
Journal:  J Ultrasound       Date:  2007-04-16

4.  Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure.

Authors:  Vanessa Stadlbauer; Peter Krisper; Reingard Aigner; Bernd Haditsch; Aleksandra Jung; Carolin Lackner; Rudolf E Stauber
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 5.  Artificial liver support systems: what is new over the last decade?

Authors:  Juan José García Martínez; Karim Bendjelid
Journal:  Ann Intensive Care       Date:  2018-11-15       Impact factor: 6.925

Review 6.  Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.

Authors:  Constantine J Karvellas; Noel Gibney; Demetrios Kutsogiannis; Julia Wendon; Vincent G Bain
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.